CCGs could face fresh pressures to fund costly drug

Clinical commissioning groups could face renewed pressure to fund an expensive thyroid drug under NHS England revised guidance, due to be published shortly.
Source: HSJ - Category: UK Health Source Type: news
More News: Thyroid | UK Health